Unilateral renal agenesis and ipsilateral absence of the vas deferens in a cryptorchid infant with Klippel-Feil syndrome

por Tanaka, Toshimitsu, Matsumoto, Fumi, Matsuyama, Satoko, Matsui, Futoshi
Publicado 2023

Fat Necrosis Mimicking Local Recurrence With Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) Positivity After Partial Nephrectomy for Renal Cell Carcinoma

por Tanaka, Toshimitsu, Yoshida, Takahiro, Maegawa, Yoko, Nakagawa, Masahiro, Kishikawa, Hidefumi
Publicado 2023

Gaps between Asian regulations for eligibility of human mesenchymal stromal cells as starting materials of cell therapy products and comparability of mesenchymal stromal cell-based...

por Tanaka, Toshimitsu, Lee, Shing-Mou, Mikami, Mayu, Yokota, Kahori, Takakura, Koji
Publicado 2020

Case report: Changes in serum bevacizumab concentration in a hemodialysis patient with unresectable colorectal cancer treated with FOLFIRI plus bevacizumab

por Tanaka, Toshimitsu, Suzuki, Hiroyuki, Ushijima, Tomoyuki, Nagasu, Sachiko, Akagi, Yoshito, Kawaguchi, Takumi, Miwa, Keisuke
Publicado 2022

Anthropometric and Other Risk Factors for Ovarian Cancer in a Case‐Control Study

por Mori, Mitsuru, Nishida, Takashi, Sugiyama, Toru, Komai, Kan, Yakushiji, Michiaki, Fukuda, Koichi, Tanaka, Toshimitsu, Yokoyama, Masatoshi, Sugimori, Hajime
Publicado 1998

Safety of Early Bevacizumab Administration after Central Venous Port Placement for Patients with Colorectal Cancer

por Shigyo, Hirona, Suzuki, Hiroyuki, Tanaka, Toshimitsu, Moriyama, Etsuko, Shimotsuura, Yasutaka, Nagasu, Sachiko, Iwamoto, Hideki, Akagi, Yoshito, Murotani, Kenta, Kawaguchi, Takumi, Miwa, Keisuke
Publicado 2023

Case Report: A case of complete response to entrectinib in NTRK fusion gene-positive parotid gland cancer

por Moriyama, Etsuko, Nagasu, Sachiko, Tanaka, Toshimitsu, Shimotsuura, Yasutaka, Ono, Takeharu, Umeno, Hirohito, Akiba, Jun, Kawahara, Akihiko, Fujita, Fumihiko, Kawaguchi, Takumi, Miwa, Keisuke
Publicado 2023

Profiles Combining Muscle Atrophy and Neutrophil-to-Lymphocyte Ratio Are Associated with Prognosis of Patients with Stage IV Gastric Cancer

por Shigeto, Kota, Kawaguchi, Takumi, Koya, Shunji, Hirota, Keisuke, Tanaka, Toshimitsu, Nagasu, Sachiko, Fukahori, Masaru, Ushijima, Tomoyuki, Matsuse, Hiroo, Miwa, Keisuke, Nagafuji, Koji, Torimura, Takuji
Publicado 2020

A phase II study of gemcitabine plus nab-paclitaxel as first-line therapy for locally advanced pancreatic cancer

por Fukahori, Masaru, Miwa, Keisuke, Murotani, Kenta, Naito, Yoshiki, Ushijima, Tomoyuki, Sakaue, Takahiko, Tanaka, Toshimitsu, Nagasu, Sachiko, Suga, Hideya, Kakuma, Tatsuyuki, Okabe, Yoshinobu, Torimura, Takuji
Publicado 2021

STAT3 deficiency prevents hepatocarcinogenesis and promotes biliary proliferation in thioacetamide-induced liver injury

por Abe, Mitsuhiko, Yoshida, Takafumi, Akiba, Jun, Ikezono, Yu, Wada, Fumitaka, Masuda, Atsutaka, Sakaue, Takahiko, Tanaka, Toshimitsu, Iwamoto, Hideki, Nakamura, Toru, Sata, Michio, Koga, Hironori, Yoshimura, Akihiko, Torimura, Takuji
Publicado 2017

High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine

por Wada, Fumitaka, Koga, Hironori, Akiba, Jun, Niizeki, Takashi, Iwamoto, Hideki, Ikezono, Yu, Nakamura, Toru, Abe, Mitsuhiko, Masuda, Atsutaka, Sakaue, Takahiko, Tanaka, Toshimitsu, Kakuma, Tatsuyuki, Yano, Hirohisa, Torimura, Takuji
Publicado 2018

Hyperlipidemia as a risk factor for Trousseau syndrome-related cerebral infarction in patients with advanced gastrointestinal cancer

por Tanaka, Toshimitsu, Suzuki, Hiroyuki, Miwa, Keisuke, Ushijima, Tomoyuki, Nagasu, Sachiko, Fukahori, Masaru, Ishii, Kaito, Nakamura, Toru, Iwamoto, Hideki, Masuda, Atsutaka, Sakaue, Takahiko, Koga, Hironori, Akagi, Yoshito, Murotani, Kenta, Torimura, Takuji
Publicado 2022

Weekends-Off Lenvatinib for Unresectable Hepatocellular Carcinoma Improves Therapeutic Response and Tolerability Toward Adverse Events

por Iwamoto, Hideki, Suzuki, Hiroyuki, Shimose, Shigeo, Niizeki, Takashi, Nakano, Masahito, Shirono, Tomotake, Okamura, Shusuke, Noda, Yu, Kamachi, Naoki, Nakamura, Toru, Masuda, Atsutaka, Sakaue, Takahiko, Tanaka, Toshimitsu, Nakano, Dan, Sakai, Miwa, Yamaguchi, Taizo, Kuromatsu, Ryoko, Koga, Hironori, Torimura, Takuji
Publicado 2020

Efficacy and tolerability of Sorafenib plus metronomic chemotherapy S-1 for advanced hepatocellular carcinoma in preclinical and clinical assessments

por Suzuki, Hiroyuki, Iwamoto, Hideki, Nakano, Masahito, Nakamura, Toru, Masuda, Atsutaka, Sakaue, Takahiko, Tanaka, Toshimitsu, Nakano, Dan, Kuromatsu, Ryoko, Niizeki, Takashi, Okamura, Shusuke, Shimose, Shigeo, Shirono, Tomotake, Noda, Yu, Kamachi, Naoki, Yano, Hirohisa, Kawaguchi, Atsushi, Koga, Hironori, Torimura, Takuji
Publicado 2021

Tumor‐derived insulin‐like growth factor‐binding protein‐1 contributes to resistance of hepatocellular carcinoma to tyrosine kinase inhibitors

por Suzuki, Hiroyuki, Iwamoto, Hideki, Seki, Takahiro, Nakamura, Toru, Masuda, Atsutaka, Sakaue, Takahiko, Tanaka, Toshimitsu, Imamura, Yasuko, Niizeki, Takashi, Nakano, Masahito, Shimose, Shigeo, Shirono, Tomotake, Noda, Yu, Kamachi, Naoki, Sakai, Miwa, Morita, Kazutoyo, Nakayama, Masamichi, Yoshizumi, Tomoharu, Kuromatsu, Ryoko, Yano, Hirohisa, Cao, Yihai, Koga, Hironori, Torimura, Takuji
Publicado 2023